MRK has reclaimed its 50-day SMA while holding above its 200-day trendline, backed by Keytruda growth, pipeline advances and ...

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. RAHWAY, N.J. – Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and ...

Merck lowered its full-year profit guidance, citing a charge tied to a recent licensing deal and $200 million in estimated additional costs for tariffs implemented to date. The company said the ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Shares of Merck slid Tuesday after the ...

Merck is recognized for its extensive product portfolio covering treatments in areas like oncology, diabetes, cardiovascular diseases, vaccines, and infectious diseases. The company also operates a ...

More biopharma layoffs are hitting New Jersey, this time from Merck & Co.in the latest phase of headcount reductions ...

Pfizer (NYSE:PFE) and Merck (NYSE:MRK) both just closed earnings chapters that frame the 2026 dividend debate clearly. Pfizer ...

Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations. The company said that sales range reflects a decision to halt shipments of Gardasil, a vaccine ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the broader biopharma industry. For the full year, Merck now expects sales ...

Merck (MRK) is set to report Q4 earnings on Tuesday, February 3, before market open. Wall Street expects EPS of $2.01, representing 16.9% year-over-year growth, on revenue of $16.21B, up 3.8% Y/Y.